Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2135)	1/15/2008 12:22:05 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

PSTI was down 15%, but is down only 14% at present, on light volume of only 3Ks.<g> bigcharts.marketwatch.com It announced last week that it has identified a second clinical indication for its PLX cells and the expansion of its pipeline of PLX products. It is expected to begin clinical trials in the second half of 2008 in Europe for the treatment of limb ischemia associated with PAD.(It seems they will need some extra $$$ to do that.<g>) The insiders control 38% of the shares & it has no institutional holders.<g>